SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057787
Filing Date
2024-05-10
Accepted
2024-05-10 16:04:10
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q revb-20240331.htm   iXBRL 10-Q 1141208
2 EX-31.1 revb-ex31_1.htm EX-31.1 26261
3 EX-31.2 revb-ex31_2.htm EX-31.2 26321
4 EX-32.1 revb-ex32_1.htm EX-32.1 10157
5 EX-32.2 revb-ex32_2.htm EX-32.2 10836
  Complete submission text file 0000950170-24-057787.txt   6238485

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20240331.xsd EX-101.SCH 1421043
64 EXTRACTED XBRL INSTANCE DOCUMENT revb-20240331_htm.xml XML 793855
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39603 | Film No.: 24934719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)